Brief: Vaxxinity Receives FDA Fast Track Designation For Ub-311 For Treatment Of Alzheimer's Disease

Vaxxinity

02/05/2022 13:57

May 2 (Reuters) - Vaxxinity Inc  VAXX.O :
    * VAXXINITY RECEIVES FDA FAST TRACK DESIGNATION FOR UB-311
FOR
TREATMENT OF ALZHEIMER’S DISEASE
    * VAXXINITY RECEIVES FDA FAST TRACK DESIGNATION FOR UB-311
FOR
TREATMENT OF ALZHEIMER’S DISEASE

Source text for Eikon:  ID:nGNXDvWhm 
Further company coverage:  VAXX.O 

 ((Reuters.Briefs@thomsonreuters.com;))